1. Home
  2. SYBT vs IOVA Comparison

SYBT vs IOVA Comparison

Compare SYBT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stock Yards Bancorp Inc.

SYBT

Stock Yards Bancorp Inc.

HOLD

Current Price

$69.01

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.47

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYBT
IOVA
Founded
1904
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2009
2008

Fundamental Metrics

Financial Performance
Metric
SYBT
IOVA
Price
$69.01
$3.47
Analyst Decision
Hold
Buy
Analyst Count
4
10
Target Price
$76.00
$9.00
AVG Volume (30 Days)
119.3K
14.0M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.81%
N/A
EPS Growth
22.11
14.84
EPS
1.24
N/A
Revenue
$23,406,000.00
N/A
Revenue This Year
$17.31
$47.74
Revenue Next Year
$9.32
$40.31
P/E Ratio
$56.43
N/A
Revenue Growth
3.37
N/A
52 Week Low
$61.51
$1.64
52 Week High
$83.83
$5.63

Technical Indicators

Market Signals
Indicator
SYBT
IOVA
Relative Strength Index (RSI) 43.66 45.56
Support Level $67.32 $3.23
Resistance Level $71.41 $4.27
Average True Range (ATR) 1.78 0.25
MACD -0.49 -0.01
Stochastic Oscillator 8.39 19.89

Price Performance

Historical Comparison
SYBT
IOVA

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: